血脑屏障
药理学
组织纤溶酶原激活剂
体内
医学
肌动蛋白解聚因子
缺血
再灌注损伤
体外
细胞骨架
化学
内科学
生物
生物化学
肌动蛋白细胞骨架
细胞
中枢神经系统
生物技术
作者
Xuewei Pan,Meijuan Wang,Shuaishuai Gong,Minhui Sun,Yan Wang,Yuanyuan Zhang,Fang Li,Boyang Yu,Junping Kou
标识
DOI:10.1016/j.jep.2020.113161
摘要
Thrombolytic therapy with tissue plasminogen activator (tPA) after ischemic stroke exacerbates blood–brain barrier (BBB) breakdown and leads to hemorrhagic transformation (HT). YiQiFuMai Lyophilized Injection (YQFM) is a modern preparation derived from Sheng-mai San (a traditional Chinese medicine). YQFM attenuates the BBB dysfunction induced by cerebral ischemia–reperfusion injury. However, whether YQFM can suppress tPA-induced HT remains unknown. We investigated the therapeutic effect of YQFM on tPA-induced HT and explored the underlying mechanisms in vivo and in vitro to improve the safety of tPA use against stroke. Male C57BL/6J mice were subjected to 45 min of ischemia and 24 h of reperfusion. tPA (10 mg/kg) were infused 2 h after occlusion and YQFM (0.671 g/kg) was injected 2.5 h after occlusion. The in vitro effect of YQFM (100, 200, 400 μg/mL) on tPA (60 μg/mL)-induced dysfunction of the microvascular endothelial barrier in the brain following oxygen-glucose deprivation/reoxygenation (OGD/R) was observed in bEnd.3 cells. YQFM suppressed tPA-induced high hemoglobin level in the brain, mortality, neurologic severity score, BBB permeability, expression and activation of matrix metalloproteinase (MMP)-9 and MMP-2, and degradation of tight-junction proteins. Furthermore, YQFM significantly blocked tPA-induced brain microvascular endothelial permeability and phosphorylation of Rho-associated kinase (ROCK)1, myosin light chain (MLC), cofilin and p65 in vivo and in vitro. YQFM suppressed tPA-induced HT by inhibiting cytoskeletal rearrangement linked with ROCK-cofilin/MLC pathways and inhibiting the nuclear factor-kappa B pathway to ameliorate BBB damage caused by tPA.
科研通智能强力驱动
Strongly Powered by AbleSci AI